How many insider declarations does 国药现代 have?

国药现代 has filed 3 insider declarations with AMF.

Who is the top reporting insider at 国药现代?

The top reporting insider at 国药现代 is 李显林, based on the count of public filings.

What is the net insider buy vs sell volume on 国药现代?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

国药现代: insider trades · France · AMF

SSE:600420FR·AMFMcap 13.5Bn€

AMF ↗

Discover the full directors' dealings record of 国药现代, a publicly traded company based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €13.5bn. The latest transaction was reported on 12 April 2023 — Purchase. Among the most active insiders: 李显林. Every trade is free.

3

Insider Decl.

0

Thresholds

·

3 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

9.13 €

Income statement

Revenue9.36 Bn€

Gross profit3.04 Bn€32% margin

Net income941.6 M€10.1% margin

Balance sheet & cash

Market cap13.55 Bn€

Total debt42.6 M€

Free Cash Flow1.43 Bn€

Last declaration on 12 April 2023

All Executives3 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations